A primer on the molecular virology of hepatitis C

Liver International

Volumn 24, Issue 6, 2004, Pages 519-525

  Moradpour, Darius ^a   Blum, Hubert E ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Helicase; Hepatitis C virus; Polymerase; Protease; Replicon

Indexed keywords

ANTIVIRUS AGENT; RNA HELICASE; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS RNA;

HEPATITIS C; HUMAN; LIFE CYCLE; MOLECULAR MECHANICS; NONHUMAN; OPEN READING FRAME; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; RNA REPLICATION; VIRION; VIRUS CLASSIFICATION; VIRUS GENOME; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; DNA, VIRAL; FORECASTING; HEPACIVIRUS; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; VIRAL STRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 11144269592     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2004.0965.x     Document Type: Review

References (54)

1. National Institutes of Health. Consensus Development Conference Statement: Management of Hepatitis C: 2002. Hepatology 2002; 36(Suppl. 1): S2-20.
2. Manns M P, McHutchison J G, Gordon S C, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358: 958-65.
3. Fried M, Shiffman M, Reddy K, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-82.
4. Hadziyannis S J, Sette H Jr., Morgan T R, et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004; 140: 346-55.
5. Muir A J, Bornstein J D, Killenberg P G for the Atlantic Coast Hepatitis Treatment Group. Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-hispanic whites. N Engl J Med 2004; 350: 2265-71.
6. Falck-Ytter Y, Kale H, Mullen K D, et al. Surprisingly small effect of antiviral treatment in patients with hepatitis C. Ann Intern Med 2002; 136: 288-92.
7. Davis G L, Albright J E, Cook S F, et al. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 2003; 9: 331-8.
8. Choo Q-L, Kuo G, Weiner A J, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
9. Kolykhalov A A, Agapov E V, Blight K J, et al. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 1997; 277: 570-4.
10. Lohmann V, Körner F, Koch J-O, et al. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999; 285: 110-3.
11. Blight K J, Kolykhalov A A, Rice C M. Efficient initiation of HCV RNA replication in cell culture. Science 2000; 290: 1972-4.
12. Bartosch B, Dubuisson J, Cosset F L. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 2003; 197: 633-42.
13. Hsu M, Zhang J, Flint M, et al. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudo-typed retroviral particles. Proc Natl Acad Sci USA 2003; 100: 7271-6.
14. Moradpour D, Brass V, Gosert R, et al. Hepatitis C: molecular virology and antiviral targets. Trends Mol Med 2002; 8: 476-82.
15. Penin F, Dubuisson J, Rey F A, et al. Structural biology of hepatitis C virus. Hepatology 2004; 39: 5-19.
16. Spahn C M, Kieft J S, Grassucci R A, et al. Hepatitis C virus IRES RNA-induced changes in the conformation of the 40S ribosomal subunit. Science 2001; 291: 1959-62.
17. Kieft J S, Zhou K, Grech A, et al. Crystal structure of an RNA tertiary domain essential to HCV IRES-mediated translation initiation. Nat Struct Biol 2002; 9: 370-4.
18. You S, Stump D D, Branch A D, Rice C M. A cis-acting replication element in the sequence encoding the NS5B RNA-dependent RNA polymerase is required for hepatitis C virus RNA replication. J Virol 2004; 78: 1352-66.
19. Tellinghuisen T L, Rice C M. Interaction between hepatitis C virus proteins and host cell factors. Curr Opin Microbiol 2002; 5: 419-27.
20. Carrère-Kremer S, Montpellier-Pala C, Cocquerel L, et al. Subcellular localization and topology of the p7 polypeptide of hepatitis C virus. J Virol 2002; 76: 3720-30.
21. Harada T, Tautz N, Thiel H J. E2-p7 region of the bovine viral diarrhea virus polyprotein: processing and functional studies. J Virol 2000; 74: 9498-506
22. Griffin S D, Beales L P, Clarke D S, et al. The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug amantadine. FEBS Lett 2003; 535: 34-8.
23. Pavlovic D, Neville D C, Argaud O, et al. The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives. Proc Natl Acad Sci USA 2003; 100: 6104-8.
24. Walewski J L, Keller T R, Stump D D, et al. Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA 2001; 7: 710-21.
25. Xu Z, Choi J, Yen T S, et al. Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J 2001; 20: 3840-8.
26. Varaklioti A, Vassilaki N, Georgopoulou U, et al. Alternate translation occurs within the core coding region of the hepatitis C viral genome. J Biol Chem 2002; 277: 17713-21.
27. Kuhn R J, Zhang W, Rossmann M G, et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 2002; 108: 717-25.
28. Mukhopadhyay S, Kim B S, Chipman P R, et al. Structure of West Nile virus. Science 2003; 302: 248.
29. Pileri P, Uematsu Y, Campagnoli S, et al. Binding of hepatitis C virus to CD81. Science 1998; 282: 938-41.
30. Agnello V, Abel G, Elfahal M, et al. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA 1999; 96: 12766-71.
31. Scarselli E, Ansuini H, Cerino R, et al. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 2002; 21: 5017-25.
32. André P, Komurian-Pradel F, Deforges S, et al Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 2002; 76: 6919-28.
33. Modis Y, Ogata S, Clements D, et al. Structure of the dengue virus envelope protein after membrane fusion. Nature 2004; 427: 313-9.
34. Gibbons D L, Vaney M C, Roussel A, et al. Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. Nature 2004; 427: 320-5.
35. Yao N, Reichert P, Taremi S S, et al. Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase. Struct Fold Des 1999; 7: 1353-63.
36. Lamarre D, Anderson P C, Bailey M, et al. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus. Nature 2003; 426: 186-9.
37. Egger D, Wölk B, Gosert R, et al. Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J Virol 2002; 76: 5974-84.
38. Gosert R, Egger D, Lohmann V, et al. Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons. J Virol 2003; 77: 5487-92.
39. Enomoto N, Sakuma I, Asahina Y, et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996; 334: 77-81.
40. Katze M G, He Y, Gale M Jr. Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2002; 2: 675-87.
41. Lesburg C A, Cable M B, Ferrari E, et al. Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat Struct Biol 1999; 6: 937-43.
42. Foy E, Li K, Wang C, et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 2003; 300: 1145-8.
43. Blight K J, McKeating J A, Marcotrigiano J, Rice C M. Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J Virol 2003; 77: 3181-90.
44. Kato T, Date T, Miyamoto M, et al. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 2003; 125: 1808-17.
45. Krieger N, Lohmann V, Bartenschlager R. Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J Virol 2001; 75: 4614-24.
46. Ikeda M, Yi M, Li K, Lemon S M. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J Virol 2002; 76: 2997-3006.
47. Pietschmann T, Lohmann V, Kaul A, et al. Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J Virol 2002; 76: 4008-21.
48. Zhu Q, Guo J T, Seeger C. Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells. J Virol 2003; 77: 9204-10.
49. Moradpour D, Evans M J, Gosert R, et al. Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes. J Virol 2004; 78: 7400-9.
50. Egger D, Gosert R, Bienz K. Role of cellular structures in viral RNA replication. In: Semler B, Wimmer E, eds. Molecular Biology of Picornaviruses. Washington, DC: ASM Press, 2002; 247-53.
51. Ahlquist P, Noueiry A O, Lee W M, et al. Host factors in positive-strand RNA virus genome replication. J Virol 2003; 71: 8181-6.
52. Dubuisson J, Penin F, Moradpour D. Interaction of hepatitis C virus proteins with host cell membranes and lipids. Trends Cell Biol 2002; 12: 517-23.
53. Neumann A U, Lam N P, Dahari H, et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 1998; 282: 103-7.
54. McLauchlan J, Lemberg M K, Hope G, et al. Intra-membrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. EMBO J 2002; 21: 3980-8.